A team of researchers from the University of Florida has developed an innovative handheld device for human immunodeficiency ...
The FDA has accepted a priority review of a new biannual HIV prevention injection, with a decision expected by June 19, 2025.
In parts of the world where traveling to a clinic for routine blood tests is a financial and logistical challenge, HIV ...
Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication. However, viruses are dynamic ...
In a joint survey by Aidsfonds, GNP+ and the Robert Carr Fund 22% of organizations reported increased experiences of discrimination, including reports of discrimination within healthcare settings, ...
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results